Kamada KMDA
NASDAQ KMDA
$8.20 -0.26 (-3.07%)
At close: Oct 1, 2026 · 4:00 PM EDT

Kamada (KMDA) Net Margin (2012 - 2026)

Updated

Kamada (KMDA) posted Net Margin of 16.86% for the quarter ended Jun 30, 2026, up 0.38 percentage points from 16.48% a year earlier and up 7.73 percentage points from the prior quarter.

Analysis

Kamada (KMDA) Net Margin (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Margin at Kamada was 11.60%, up 0.38 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 11.19%, up 2.21 percentage points from the prior year.

  • Annual Net Margin has increased for four consecutive years, with a four-year change of +13.34 percentage points (years ended Dec 2021 to Dec 2025).
  • In prior years, Kamada's Net Margin was 8.99% in the year ended Dec 31, 2024 (+3.17 pp), 5.81% in the year ended Dec 31, 2023 (+7.61 pp), -1.79% in the year ended Dec 31, 2022 (+0.36 pp) and -2.15% in the year ended Dec 31, 2021.
  • The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly Net Margin since the quarter ended Sep 30, 2020.
  • On a year-over-year basis, Net Margin increased in six of the last eight quarters, with an average year-over-year change of +0.77 percentage points.
  • The strongest year-over-year quarter for Net Margin in the past five years was the quarter ended Dec 31, 2022, with a gain of 22.40 percentage points; the weakest was the quarter ended Sep 30, 2021, with a drop of 23.02 percentage points.
  • According to Business Quant data, Net Margin for the three prior quarters was 9.13% (quarter ended Mar 31, 2026), 7.97% (quarter ended Dec 31, 2025) and 11.27% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 21.86%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 21.27%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -8.04%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 22.61%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 18.81%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 23.62%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -134.51%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 32.99%
10 Kamada 488.02 Mn 197.08 Mn 22.47 Mn 16.86%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.86%
Mar 31, 2026 9.13%
Dec 31, 2025 7.97%
Sep 30, 2025 11.27%
Jun 30, 2025 16.48%
Mar 31, 2025 9.01%
Dec 31, 2024 9.76%
Sep 30, 2024 9.25%
Jun 30, 2024 10.42%
Mar 31, 2024 6.27%
Dec 31, 2023 13.88%
Sep 30, 2023 8.50%
Jun 30, 2023 4.84%
Mar 31, 2023 -5.89%
Dec 31, 2022 6.48%
Sep 30, 2022 1.50%
Jun 30, 2022 -16.62%
Mar 31, 2022 -6.51%
Dec 31, 2021 -15.92%
Sep 30, 2021 -3.67%
API Access

Kamada Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=KMDA&period=max&api_key=YOUR_API_KEY